An Organ-On-Chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-On-Chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels. The primary focus of Organ-On-Chip technology is the re-creation of three key aspects of human physiology: the multicellular vascular or epithelial interfaces of organs (for example, blood vessel networks, lung and gut), which function as barriers in tissues; the tissue-level organization of parenchymal cells (for example, liver, heart, skeletal muscle and tumours), which are responsible for the key functional properties of an organ; and the systematic interaction of multiple organs (for example, drug absorption, distribution, metabolism and elimination involving the gut, circulation, liver and kidney). In addition, the Blood-Brain Barrier is definitely more complex than a simple wall, controlling the passage of most solute that enters or leaves the brain. To address how this molecular sieve affects neural activity, some researchers have simulated the interaction between blood vessels and brain tissue on a series of interconnected "organ chips" when connected through this Blood-Brain Barrier (BBB) model. Endothelial cells, pericytes, astrocytes and neurons alter their gene expression. These technologies will achieve even more rapid development and application.
Highlights
The global Organ-on-a-chip Systems market was valued at US$ 72 million in 2022 and is anticipated to reach US$ 195.5 million by 2029, witnessing a CAGR of 18.0% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global main manufacturers of organ-on-chip include Emulate, Mimetas and TissUse, etc. The top three players hold a share about 40%. The global organ-on-chip is mainly produced in United States and Europe, they occupied for a share over 80%. North America is the largest market, has a share about 43%, followed by Europe and Japan, with share 37% and 8%, separately.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Organ-on-a-chip Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Organ-on-a-chip Systems.
The Organ-on-a-chip Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Organ-on-a-chip Systems market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Organ-on-a-chip Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
Segment by Type
Liver-on-a-chip
Kidney-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Intestine-on-a-chip
Brain-on-a-chip
Other Organs
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Organ-on-a-chip Systems companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Organ-on-a-chip Systems Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Liver-on-a-chip
1.2.3 Kidney-on-a-chip
1.2.4 Lung-on-a-chip
1.2.5 Heart-on-a-chip
1.2.6 Intestine-on-a-chip
1.2.7 Brain-on-a-chip
1.2.8 Other Organs
1.3 Market by Application
1.3.1 Global Organ-on-a-chip Systems Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Cosmetics Industry
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Organ-on-a-chip Systems Market Perspective (2018-2029)
2.2 Organ-on-a-chip Systems Growth Trends by Region
2.2.1 Global Organ-on-a-chip Systems Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Organ-on-a-chip Systems Historic Market Size by Region (2018-2023)
2.2.3 Organ-on-a-chip Systems Forecasted Market Size by Region (2024-2029)
2.3 Organ-on-a-chip Systems Market Dynamics
2.3.1 Organ-on-a-chip Systems Industry Trends
2.3.2 Organ-on-a-chip Systems Market Drivers
2.3.3 Organ-on-a-chip Systems Market Challenges
2.3.4 Organ-on-a-chip Systems Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Organ-on-a-chip Systems Players by Revenue
3.1.1 Global Top Organ-on-a-chip Systems Players by Revenue (2018-2023)
3.1.2 Global Organ-on-a-chip Systems Revenue Market Share by Players (2018-2023)
3.2 Global Organ-on-a-chip Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Organ-on-a-chip Systems Revenue
3.4 Global Organ-on-a-chip Systems Market Concentration Ratio
3.4.1 Global Organ-on-a-chip Systems Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Organ-on-a-chip Systems Revenue in 2022
3.5 Organ-on-a-chip Systems Key Players Head office and Area Served
3.6 Key Players Organ-on-a-chip Systems Product Solution and Service
3.7 Date of Enter into Organ-on-a-chip Systems Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Organ-on-a-chip Systems Breakdown Data by Type
4.1 Global Organ-on-a-chip Systems Historic Market Size by Type (2018-2023)
4.2 Global Organ-on-a-chip Systems Forecasted Market Size by Type (2024-2029)
5 Organ-on-a-chip Systems Breakdown Data by Application
5.1 Global Organ-on-a-chip Systems Historic Market Size by Application (2018-2023)
5.2 Global Organ-on-a-chip Systems Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Organ-on-a-chip Systems Market Size (2018-2029)
6.2 North America Organ-on-a-chip Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Organ-on-a-chip Systems Market Size by Country (2018-2023)
6.4 North America Organ-on-a-chip Systems Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Organ-on-a-chip Systems Market Size (2018-2029)
7.2 Europe Organ-on-a-chip Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Organ-on-a-chip Systems Market Size by Country (2018-2023)
7.4 Europe Organ-on-a-chip Systems Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Organ-on-a-chip Systems Market Size (2018-2029)
8.2 Asia-Pacific Organ-on-a-chip Systems Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Organ-on-a-chip Systems Market Size by Region (2018-2023)
8.4 Asia-Pacific Organ-on-a-chip Systems Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Organ-on-a-chip Systems Market Size (2018-2029)
9.2 Latin America Organ-on-a-chip Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Organ-on-a-chip Systems Market Size by Country (2018-2023)
9.4 Latin America Organ-on-a-chip Systems Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Organ-on-a-chip Systems Market Size (2018-2029)
10.2 Middle East & Africa Organ-on-a-chip Systems Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Organ-on-a-chip Systems Market Size by Country (2018-2023)
10.4 Middle East & Africa Organ-on-a-chip Systems Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Emulate
11.1.1 Emulate Company Detail
11.1.2 Emulate Business Overview
11.1.3 Emulate Organ-on-a-chip Systems Introduction
11.1.4 Emulate Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.1.5 Emulate Recent Development
11.2 TissUse
11.2.1 TissUse Company Detail
11.2.2 TissUse Business Overview
11.2.3 TissUse Organ-on-a-chip Systems Introduction
11.2.4 TissUse Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.2.5 TissUse Recent Development
11.3 Hesperos
11.3.1 Hesperos Company Detail
11.3.2 Hesperos Business Overview
11.3.3 Hesperos Organ-on-a-chip Systems Introduction
11.3.4 Hesperos Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.3.5 Hesperos Recent Development
11.4 CN Bio Innovations
11.4.1 CN Bio Innovations Company Detail
11.4.2 CN Bio Innovations Business Overview
11.4.3 CN Bio Innovations Organ-on-a-chip Systems Introduction
11.4.4 CN Bio Innovations Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.4.5 CN Bio Innovations Recent Development
11.5 Tara Biosystems
11.5.1 Tara Biosystems Company Detail
11.5.2 Tara Biosystems Business Overview
11.5.3 Tara Biosystems Organ-on-a-chip Systems Introduction
11.5.4 Tara Biosystems Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.5.5 Tara Biosystems Recent Development
11.6 Draper Laboratory
11.6.1 Draper Laboratory Company Detail
11.6.2 Draper Laboratory Business Overview
11.6.3 Draper Laboratory Organ-on-a-chip Systems Introduction
11.6.4 Draper Laboratory Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.6.5 Draper Laboratory Recent Development
11.7 Mimetas
11.7.1 Mimetas Company Detail
11.7.2 Mimetas Business Overview
11.7.3 Mimetas Organ-on-a-chip Systems Introduction
11.7.4 Mimetas Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.7.5 Mimetas Recent Development
11.8 Nortis
11.8.1 Nortis Company Detail
11.8.2 Nortis Business Overview
11.8.3 Nortis Organ-on-a-chip Systems Introduction
11.8.4 Nortis Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.8.5 Nortis Recent Development
11.9 Micronit Microtechnologies B.V.
11.9.1 Micronit Microtechnologies B.V. Company Detail
11.9.2 Micronit Microtechnologies B.V. Business Overview
11.9.3 Micronit Microtechnologies B.V. Organ-on-a-chip Systems Introduction
11.9.4 Micronit Microtechnologies B.V. Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.9.5 Micronit Microtechnologies B.V. Recent Development
11.10 Kirkstall
11.10.1 Kirkstall Company Detail
11.10.2 Kirkstall Business Overview
11.10.3 Kirkstall Organ-on-a-chip Systems Introduction
11.10.4 Kirkstall Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.10.5 Kirkstall Recent Development
11.11 Cherry Biotech SAS
11.11.1 Cherry Biotech SAS Company Detail
11.11.2 Cherry Biotech SAS Business Overview
11.11.3 Cherry Biotech SAS Organ-on-a-chip Systems Introduction
11.11.4 Cherry Biotech SAS Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.11.5 Cherry Biotech SAS Recent Development
11.12 Else Kooi Laboratory
11.12.1 Else Kooi Laboratory Company Detail
11.12.2 Else Kooi Laboratory Business Overview
11.12.3 Else Kooi Laboratory Organ-on-a-chip Systems Introduction
11.12.4 Else Kooi Laboratory Revenue in Organ-on-a-chip Systems Business (2018-2023)
11.12.5 Else Kooi Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory
听
听
*If Applicable.
